Tag: study

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In UroGen Pharma (URGN) To Contact Him Directly To Discuss Their Options

– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms –

– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms –

Explore the PFAS Filtration Companies Quadrant, a comprehensive study revealing key players like Veolia, AECOM, and Xylem leading the global PFAS filtration market. As environmental concerns over per-and polyfluoroalkyl substances (PFAS) rise, driven by their widespread use and environmental impact, effective filtration solutions become crucial. The industry's growth is fueled by regulatory mandates and public health concerns. Key technologies include activated carbon adsorption, reverse osmosis, and ion exchange resins, with municipalities and sectors like aerospace investing heavily in PFAS solutions. Discover the top 15 companies shaping this rapidly growing market.